[{"id":"2cfb63f8-caef-4e92-b1d4-4723a0502155","acronym":"","url":"https://clinicaltrials.gov/study/NCT01463956","created_at":"2021-10-27T14:53:03.432Z","updated_at":"2025-02-25T16:02:01.047Z","phase":"Phase 2","brief_title":"Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation","source_id_and_acronym":"NCT01463956","lead_sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","biomarkers":" IFNL3 • ITPA","pipe":"","alterations":" ","tags":["IFNL3 • ITPA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ViraferonPeg (peginterferon-α-2b)"],"overall_status":"Completed","enrollment":" Enrollment 58","initiation":"Initiation: 01/06/2012","start_date":" 01/06/2012","primary_txt":" Primary completion: 06/01/2014","primary_completion_date":" 06/01/2014","study_txt":" Completion: 01/22/2015","study_completion_date":" 01/22/2015","last_update_posted":"2017-01-24"}]